Methylprednisolone Recruiting Phase 2 Trials for Novel Coronavirus Infectious Disease (COVID-19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04329650Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia